Beludavimab Biosimilar - Research Grade

Human

Severe acute respiratory syndrome coronavirus 2

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

Blue ice

Antibodies directed at the SARS-CoV-2 spike glycoprotein, the principal determinant of viral attachment, are core tools for neutralizing-antibody and coronavirus immunology research. This product is an unconjugated, non-therapeutic analog of beludavimab, a human IgG1-kappa recombinant monoclonal supplied strictly for research use only (RUO). It is formulated with low endotoxin to in vivo-grade standards and produced in scalable milligram-to-gram quantities, supporting heavy-usage and high-throughput virology laboratories that consume reagents in bulk. Suitable applications include neutralization and functional assays, spike-binding characterization, in vitro screening and preclinical models of coronavirus infection, with dependable consistency maintained from lot to lot.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks